首页> Critical reviews in oncology/hematology> Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review.

Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review.

导出 LinkOut

翻译打印收藏纠错

第一作者： Alessandro,Nepote

第一单位： Oncology Unit, San Luigi Gonzaga Hospital, Department of Oncology, University of Turin, Regione Gonzole 10, Orbassano 10043, Italy.

作者： Alessandro,Nepote ^[1] ; Stefano,Poletto ^[1] ; Valentina,Bertaglia ^[2] ; Simona,Carnio ^[1] ; Carlo,Piumatti ^[1] ; Cristina,Lanzetta ^[1] ; Ornella,Cantale ^[1] ; Giorgio,Saba ^[3] ; Paolo,Bironzo ^[1] ; Silvia,Novello ^[1] ; Antonino Carmelo,Tralongo ^[4]

作者单位： Oncology Unit, San Luigi Gonzaga Hospital, Department of Oncology, University of Turin, Regione Gonzole 10, Orbassano 10043, Italy. ^[1] Oncology Unit, San Luigi Gonzaga Hospital, Department of Oncology, University of Turin, Regione Gonzole 10, Orbassano 10043, Italy. Electronic address: v.bertaglia@sanluigi.piemonte.it. ^[2] Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari 09042, Italy. ^[3] Medical Oncology Unit, Umberto I Hospital, Azienda Sanitaria Provinciale (ASP) Siracusa, Siracusa 96100, Italy. ^[4]

关键词 Brain metastases Brain radiotherapy Meta-analysis Non small cell lung cancer Osimertinib Targeted therapy